GYRE earnings: a negative outcome, -5.9%

On March 4, 2021, GYRE THERAPEUTICS, INC. reached its earnings. The result was a negative outcome, and the stock moved -5.9% in the window around the event. It had already run +6.7% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.